METR is developing evaluations for AI R&D capabilities, such that evaluators can determine if further AI development risks a "capabilities explosio...
Prellis Biologics uses proprietary technology to 3D print lymph node organoids, which we are using to generate in vitro antibody libraries and in v...
Built at: 2024-11-15T02:34:04.847Z